BryanHaugenMD
Endocrinology • Aurora, COThyroid
Professor of Medicine, University Colorado School of Medicine, Head, Division of Endocrinology, Metabolism and Diabetes
Dr. Haugen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12801 E 17th Ave
Room 7100
Aurora, CO 80045Phone+1 303-724-3921Fax+1 303-724-3920
Education & Training
University of ColoradoFellowship, Endocrinology, Diabetes, and Metabolism, 1990 - 1993- University of ColoradoResidency, Internal Medicine, 1987 - 1990
Mayo Clinic College of MedicineClass of 1987
Certifications & Licensure
CO State Medical License 1989 - 2025
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Is Levothyroxine Alone Adequate Thyroid Hormone Replacement? Start of enrollment: 2016 Nov 01
- Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) Start of enrollment: 2018 Feb 07
Publications & Presentations
PubMed
- Long term outcomes after repeat lymph node dissections for persistent or recurrent differentiated thyroid cancer.Martin Jose Barrio, Nikita Pozdeyev, Robert C McIntyre Jr, Maria B Albuja-Cruz, Bryan R Haugen
American Journal of Surgery. 2025-01-01 - Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy.Martin Jose Barrio, Nikita Pozdeyev, Christopher D Raeburn, Robert C McIntyre Jr, Carrie B Marshall
American Journal of Surgery. 2024-12-01 - Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers.Jena D French, Bryan R Haugen, Francis P Worden, Daniel W Bowles, Andrew G Gianoukakis
Clinical Cancer Research. 2024-09-03
Press Mentions
CU Cancer Center Research Tests Two-Drug Treatment for Progressive Thyroid CancerSeptember 23rd, 2024- Preview of the 93rd American Thyroid Association Annual MeetingJuly 1st, 2024
- To Wait or To Cut: How to Proceed with Small Thyroid TumorsAugust 17th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
